Ȩ Ä«Å×°í¸® ¸ÂÃãÇü½ÃÀåÁ¶»ç ±¹Á¦ÄÁÆÛ·±½º ±Û·Î¹ú ÆÄÆ®³Ê ¸ÞÀϸµ ¼­ºñ½º ȸ»ç¼Ò°³È¸»ç¼Ò°³ Contact Us
English Japaness Chinese
Home > ½ÃÀ庸°í¼­ > ÆÄ¸Ó½´Æ¼Äà > European Gastroenterology Therapeutics Markets
Ä«Å×°í¸®
ÆÄ¸Ó½´Æ¼Äà (4931)
°¨¿°Áúȯ (349)
°ñÁúȯ Ä¡·á (38)
´ç´¢º´ (194)
¹é½Å (181)
ºñ¸¸Ä¡·á/´ÙÀÌ¾îÆ® (44)
ºñó¹æ ÀǾàǰ (152)
¼öÀÇÇÐ (17)
½Å°æÁúȯ (174)
½Å¾à°³¹ß (1529)
¾ÏÄ¡·á (941)
¾à¹°Àü´Þ (185)
ÀǾàǰ ±ÔÁ¦È¯°æ (127)
Á¤½ÅÁúȯ (86)
Á¦³×¸¯ ÀǾàǰ (128)
Á¦¾àȸ»çºÐ¼® (523)
󹿾à (165)
½ÃÀ庸°í¼­

European Gastroenterology Therapeutics Markets

¸®¼­Ä¡»ç Frost & Sullivan
¹ßÇàÀÏ 2007³â 11¿ù »óǰÄÚµå 58037
ÆäÀÌÁö Á¤º¸
°¡°Ý
US $ 6,500 £Ü 7,744,700 Web Access (Regional License)
US $ 7,000 £Ü 8,340,500 Hard Copy & Web Access (Regional License)


¿µ¹®¸ñÂ÷

Abstract

This Frost & Sullivan research service titled European Gastroenterology Therapeutics Markets provides an overview of current treatment options, technological advancements and revenues, along with a complete analysis of key prevailing drivers, restraints and trends. In this research, Frost & Sullivan' s expert analysts thoroughly examine the following market: proton pump inhibitors, histamine-2 receptor antagonists, intestinal anti-inflammatory agents, immunosuppressive agents.

This research service is available through our Pharmaceuticals & Biotechnology Growth Partnership Services programme. With this programme, you receive industry-leading market research such as this, along with technical and econometric data and many interactive features including Analyst Inquiry Time and Client Councils.

Table of Contents

1 EXECUTIVE SUMMARY

  • Executive Summary of the European Gastroenterology Therapeutics Market
    • Executive Summary

2 RESEARCH METHODOLOGY

  • Research Methodology for the European Gastroenterology Therapeutics Market
    • Methodology
  • Research Scope and Segmentation
    • Research Scope for the European Gastroenterology Therapeutics Market
    • Segmentation for the European Gastroenterology Therapeutics Market

3 INDUSTRY CHALLENGES

  • Challenges Facing the European Gastroenterology Therapeutics Market
    • Challenges Facing the Market

4 EUROPEAN GASTROENTEROLOGY THERAPEUTICS MARKET OUTLOOK

  • Introduction
    • Diseases Overview
  • Gastroesophageal Reflux Disease (GERD)
    • Disease Description
    • Epidemiology
    • Current Treatment Options
  • Peptic Ulcer Disease (PUD)
    • Disease Description
    • Epidemiology
    • Current Treatment Options
  • Inflammatory Bowel Disease (IBD)
    • Disease Description
    • Epidemiology
    • Current Treatment Options

5 MARKET ENGINEERING RESEARCH FOR THE EUROPEAN GASTROENTEROLOGY THERAPEUTICS MARKET

  • European Gastroenterology Therapeutics
    • Market Overview
    • Market Engineering Measurements
    • Market Drivers
    • Market Restraints
    • Revenue Forecasts
    • Trends by Segment

6 COMPETITOR ANALYSIS

  • Portfolio Analysis
    • Key Competitor Analysis

7 STRATEGIC RECOMMENDATIONS FOR THE EUROPEAN GASTROENTEROLOGY THERAPEUTICS MARKET

  • Strategic Recommendations
    • Market Engineering Recommendations

8 DATABASE OF KEY INDUSTRY PARTICIPANTS

  • Key Industry Participants
    • Major Participants

9 APPENDIX

  • Decision Support Database
    • Smokers
    • Female Smokers
    • Male Smokers
    • Government Healthcare Expenditure
    • Stomach Cancer Incidence
Back to Top